TinyGemsBreaks Archive

ThursdayJun 05, 2025 1:39 pm

TinyGemsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Unveils Promising Data on CLD-401 at ASCO 2025

Calidi Biotherapeutics (NYSE American: CLDI) is a clinical-stage biotechnology company pioneering the development of systemic oncolytic targeted immunotherapies with the ability to deliver genetic payloads. The company unveiled promising new data on its lead RedTail platform candidate, CLD-401, at the American Society of Clinical Oncology (“ASCO”) Annual Meeting. The announcement reads, “Calidi has previously demonstrated its pioneering efforts in developing an enveloped form of its proprietary oncolytic virus that is significantly more resistant to immune clearance than non-enveloped forms, allowing for systemic delivery and efficacy in syngeneic tumor-bearing pre-clinical models. Calidi has further advanced this technology with CLD-401, its first…

ThursdayJun 05, 2025 9:50 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present Promising Glioblastoma Data at Brain Tumor Biotech Summit

CNS Pharmaceuticals (NASDAQ: CNSP) announced that Chief Medical Officer Sandra Silberman, M.D., Ph.D., will present at the Brain Tumor Biotech Summit hosted by Lenox Hill Hospital’s Department of Neurosurgery on June 5, 2025. Her presentation, titled "The Future and Promise of TPI 287," will highlight CNS’s brain-penetrating taxane candidate, which has shown efficacy in glioblastoma patients, including 3 complete and 9 partial responses in a Phase 1 trial. TPI 287, which has FDA Orphan Drug Designation for gliomas, pediatric neuroblastoma, and progressive supranuclear palsy, may offer a breakthrough in treating CNS tumors by effectively crossing the blood-brain barrier. To view…

ThursdayJun 05, 2025 9:20 am

TinyGemsBreaks – SolarBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) to Allocate Solar Project Revenue to Bitcoin Treasury Strategy

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) has taken its first step toward implementing a Bitcoin treasury strategy by committing net revenue from its 3.79 MW Geddes Solar Power Project to Bitcoin purchases. This initiative places SolarBank among the early renewable energy companies integrating digital assets into corporate finance. The Geddes Project, built on a repurposed landfill, is expected to begin operations by the end of June 2025. CEO Dr. Richard Lu described the move as a strategic blend of stable energy cash flow and Bitcoin’s appreciation potential, with future expansions of the…

TuesdayJun 03, 2025 11:35 am

TinyGemsBreaks – ECGI Holdings Inc. (OTC: ECGI) Backs AI-Focused Startup TrueToForm in First Uplist Ventures Deal

ECGI Holdings (OTC: ECGI), a diversified holding company targeting innovation-led sectors, announced that its investment arm, Uplist Ventures, has completed its first deal by backing AI and 3D computer vision startup TrueToForm. The startup, also backed by MassChallenge, Dartmouth Angels, and Chicago Booth Angels, offers a patented AI body scanning platform designed to reduce e-commerce apparel returns—a $38 billion problem—by creating 97%-accurate digital avatars. ECGI’s own Pacific Saddlery brand already uses TrueToForm for custom fittings. With over 50 clients and a pipeline of 25 brands, TrueToForm is scaling fast. ECGI executives said the deal signals the company’s strategy to support…

TuesdayJun 03, 2025 9:50 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Relaunches FIVE RS EV for German Market with FPF Partnership

Mullen Automotive (NASDAQ: MULN) announced the relaunch of its ultra-high-performance Mullen FIVE RS EV Crossover, with vehicle sales targeted to begin in Germany by December 2025. Following successful 800V battery testing at TUV SUD in Munich, the vehicle is entering on-road validation as part of its final homologation process. Mullen has partnered with Germany-based Faissner Petermeier Fahrzeugtechnik AG (FPF), a veteran automotive engineering and manufacturing firm, to ensure production meets the highest global standards. The FIVE RS boasts a top speed of 200 mph, 0–60 acceleration under two seconds, and over 1,100 horsepower. Mullen plans to expand sales across the EU,…

MondayJun 02, 2025 11:15 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Increases Ownership of Bollinger Motors to 95%, Resolves Receivership

Mullen Automotive (NASDAQ: MULN) has acquired an additional 21% stake in Bollinger Motors, bringing its total ownership to 95% and increasing shareholder equity by approximately $3.5 million. The move follows Mullen’s resolution of outstanding claims and debt that had placed Bollinger under court-ordered receivership, a case now dismissed with prejudice. Bollinger will continue operating independently under Mullen’s ownership, with its commercial EV lineup—led by the all-electric B4 Chassis Cab—receiving full support for sales, service, and warranty. Mullen plans to leverage synergies to accelerate the B4’s development and drive growth within the commercial EV space. To view the full press release, visit…

ThursdayMay 29, 2025 9:20 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) to Implement 1-for-100 Reverse Stock Split on June 2

Mullen Automotive (NASDAQ: MULN) announced it will enact a 1-for-100 reverse stock split effective June 2, 2025, aiming to regain compliance with Nasdaq’s $1.00 minimum bid price requirement. Approved by shareholders on May 21 and finalized by the board, the reverse split will reduce Mullen’s outstanding common shares from approximately 80 million to about 800,000, with trading to begin on a split-adjusted basis under the same ticker symbol. No fractional shares will be issued, and all existing equity instruments and convertible securities will be proportionally adjusted, excluding the 2022 Equity Incentive Plan, which remains unchanged. To view the full press release,…

TuesdayMay 27, 2025 11:36 am

TinyGemsBreaks – NextPlat Corp. (NASDAQ: NXPL) Announces Passing of CEO Charles M. Fernandez, Appoints Interim Leadership

NextPlat (NASDAQ: NXPL, NXPLW) announced with deep sadness the sudden passing of Executive Chairman and CEO Charles M. Fernandez on May 24. Fernandez had led the company since July 2021. The Board has appointed Rodney Barreto, Chair of the Audit Committee, as Interim Chairman, and David Phipps, current President and CEO of Global Operations, as Interim CEO. Vice Chairman Doug Ellenoff expressed condolences, noting Fernandez’s dedication to family and the company. Barreto, a director since 2022, brings over 35 years of business and civic leadership, while Phipps previously led NextPlat through its early growth and Nasdaq listing. The company is…

TuesdayMay 27, 2025 10:16 am

TinyGemsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Advances 6.9 MW Community Solar Project in Nova Scotia

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) will develop the 6.9 MW DC Brooklyn solar project in Nova Scotia under Canada’s first Community Solar Program. Owned by AI Renewable Fund, the $13.9 million project will be built in partnership with local firm Trimac Engineering. The program supports Nova Scotia’s goal of reaching 80% renewable energy by 2030 and net-zero by 2035. SolarBank will oversee interconnection, permitting, and design through 2025, with construction expected to begin in spring 2026. The company also disclosed a shares-for-services agreement with an independent advisor valued at up to…

ThursdayMay 22, 2025 3:11 pm

TinyGemsBreaks – Calidi Biotherapeutics Inc.’s (NYSE American: CLDI) RTNova Shows Promise in Targeted Tumor Therapy

Calidi Biotherapeutics (NYSE American: CLDI) recently announced promising preclinical results for its RTNova platform, a breakthrough in the delivery of transient gene therapy payloads to targeted tumors. The innovative platform not only targets cancer cells effectively but also minimizes harm to surrounding healthy tissues, potentially improving treatment outcomes and reducing side effects. As global cancer rates continue to rise, Calidi’s RTNova platform and tumor-specific virotherapy hold the promise of offering new hope to cancer patients, addressing the limitations of existing treatments, and potentially improving survival rates across multiple cancer types. The company’s ongoing research and deep commitment to scientific excellence position…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks